Trial intelligence / Profile preview

Dexmedetomidine as an adjunct to general anesthesia in traumatic brain injury craniectomy

ChiCTR2000029501Phase 4Completed

Sponsor
Handan Central Hospital
Start
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine in traumatic brain injury (TBI) (2 arms), sponsored by Handan Central Hospital. Primary endpoints: blood pressure, heart rate and 4 more. Started Feb 2010; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on ChiCTR2000029501.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000029501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call